Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
Xencor profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Xencor's profit margin for the twelve months ending Jun 30, 2026 was -155.6%. For fiscal 2025 it was -73.2%, against -210.5% the year before. The highest annual figure on record is 41.4% in fiscal 2016.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -73.2% | +137.3 |
| FY2024 | Dec 31, 2024 | -210.5% | −134.3 |
| FY2023 | Dec 31, 2023 | -76.2% | −42.7 |
| FY2022 | Dec 31, 2022 | -33.5% | −63.6 |
| FY2021 | Dec 31, 2021 | 30.0% | +86.5 |
| FY2020 | Dec 31, 2020 | -56.5% | −73.7 |
| FY2019 | Dec 31, 2019 | 17.2% | +190.6 |
| FY2018 | Dec 31, 2018 | -173.4% | −90.0 |
| FY2017 | Dec 31, 2017 | -83.4% | −124.8 |
| FY2016 | Dec 31, 2016 | 41.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -42.4% | +28.3 |
| Q1 FY2026 | Mar 31, 2026 | -2854.7% | −2706.7 |
| Q4 FY2025 | Dec 31, 2025 | -23.6% | +62.7 |
| Q3 FY2025 | Sep 30, 2025 | -28.7% | +231.4 |
| Q2 FY2025 | Jun 30, 2025 | -70.7% | +211.0 |
| Q1 FY2025 | Mar 31, 2025 | -147.9% | +311.2 |
| Q4 FY2024 | Dec 31, 2024 | -86.3% | −35.0 |
| Q3 FY2024 | Sep 30, 2024 | -260.1% | −219.1 |
| Q2 FY2024 | Jun 30, 2024 | -281.7% | −233.4 |
| Q1 FY2024 | Mar 31, 2024 | -459.1% | −138.6 |
| Q4 FY2023 | Dec 31, 2023 | -51.3% | +4.4 |
| Q3 FY2023 | Sep 30, 2023 | -41.0% | +79.0 |
| Q2 FY2023 | Jun 30, 2023 | -48.2% | +64.4 |
| Q1 FY2023 | Mar 31, 2023 | -320.4% | −348.0 |
| Q4 FY2022 | Dec 31, 2022 | -55.7% | −103.2 |
| Q3 FY2022 | Sep 30, 2022 | -120.0% | +84.2 |
| Q2 FY2022 | Jun 30, 2022 | -112.6% | −190.1 |
| Q1 FY2022 | Mar 31, 2022 | 27.6% | +34.9 |
| Q4 FY2021 | Dec 31, 2021 | 47.4% | +80.1 |
| Q3 FY2021 | Sep 30, 2021 | -204.2% | −168.7 |
| Q2 FY2021 | Jun 30, 2021 | 77.5% | +345.0 |
| Q1 FY2021 | Mar 31, 2021 | -7.3% | +17.6 |
| Q4 FY2020 | Dec 31, 2020 | -32.7% | +732.7 |
| Q3 FY2020 | Sep 30, 2020 | -35.5% | +11.5 |
| Q2 FY2020 | Jun 30, 2020 | -267.5% | −185.2 |
| Q1 FY2020 | Mar 31, 2020 | -24.9% | −96.4 |
| Q4 FY2019 | Dec 31, 2019 | -765.4% | −608.1 |
| Q3 FY2019 | Sep 30, 2019 | -47.0% | −57.8 |
| Q2 FY2019 | Jun 30, 2019 | -82.3% | −106.7 |
| Q1 FY2019 | Mar 31, 2019 | 71.5% | +133.3 |
| Q4 FY2018 | Dec 31, 2018 | -157.4% | +284.8 |
| Q3 FY2018 | Sep 30, 2018 | 10.8% | – |
| Q4 FY2017 | Dec 31, 2017 | 24.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -61.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -442.1% | – |
See a number that looks wrong?